Ryan Zeidan
Vorstandsvorsitzender bei Sling Therapeutics, Inc.
Aktive Positionen von Ryan Zeidan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Präsident | - | - |
Karriereverlauf von Ryan Zeidan
Ehemalige bekannte Positionen von Ryan Zeidan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MILLENDO THERAPEUTICS | Corporate Officer/Principal | 20.08.2019 | 29.01.2021 |
Ausbildung von Ryan Zeidan
California Institute of Technology | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Commercial Services |
- Börse
- Insiders
- Ryan Zeidan
- Erfahrung